BioMarin Pharmaceutical (BMRN) shares ended the last trading session 6.3% higher at 59.43.Thejumpcameonanimpressivevolumewithahigher−than−averagenumberofshareschanginghandsinthesession.Thiscomparestothestock′s20.759.43. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 20.7% loss over the past four weeks.The rise in share price came after President Trump announced a 90-day pause on his sweeping tariffs against non-retaliating countries.This rare disease biopharmaceutical is expected to post quarterly earnings of 59.43.Thejumpcameonanimpressivevolumewithahigher−than−averagenumberofshareschanginghandsinthesession.Thiscomparestothestock′s20.70.95 per share in its upcomin ...
BioMarin Pharmaceutical(BMRN) ZACKS·2025-04-10 13:20